From: healthline.com The importance of self-exams The American Cancer Society’s (ACS) most recent guidelinesTrusted Source reflect that self-exams haven’t shown a clear benefit, especially for women who also get screening mammograms, even when doctors conduct those exams. Still, some men and women will find breast cancer and be diagnosed with it as a result of a lump detected during a …
Health Literacy Supports Workforce Reintegration for Breast Cancer Survivors
By: Megan Garlapow, PhD From: oncologynurseadvisor.com Given the substantial impact of health literacy on return-to-work outcomes, healthcare providers should integrate educational interventions alongside psychological support strategies. Survivors of breast cancer face significant challenges in returning to work, with fear of cancer recurrence playing a crucial role in their reintegration into the workforce, according to a study published in the Journal …
6 Ways to Stay Socially Connected While Undergoing Breast Cancer Treatment
From: healthline.com Staying connected with friends after a breast cancer diagnosis can be challenging — even when plenty of people are offering help and wishing you well. Receiving a breast cancer diagnosis is a deeply personal experience and facing the challenges of living with and treating cancer can feel overwhelming. It’s natural to want time to yourself to process your …
Novel radiotracer identifies biomarker for triple-negative breast cancer
By: Society of Nuclear Medicine and Molecular Imaging From: medicalxpress.com A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC). According to research published in the March issue of The Journal of Nuclear Medicine, the PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of this …
Moffitt Study Identifies Immune Response That May Stop Breast Cancer from Spreading
By: Moffitt Cancer Center From: onclive.com A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer cells within the body. Published in Cancer Immunology Research, the study shows that activating certain immune cells can stop dormant cancer cells from growing into new tumors. The researchers discovered that CD4+ Th1 cells, …
AI reduces false positives by 37.3% in breast cancer diagnosis
By: BGI Genomics From: medicalxpress.com Despite making up half of the global population, women’s health has often been sidelined by traditional health care systems. Systemic neglect has led to delayed diagnoses and inadequate care. Artificial intelligence (AI) is emerging as a transformative force in women’s health care, enhancing clinical decision-making, improving diagnostic accuracy, and guiding treatments for better outcomes. Historically …
Vepdegestrant Demonstrates Progression-Free Survival in Patients With ER+/HER2- Metastatic Breast Cancer
From: pharmacytimes.com Vepdegestrant (ARV-471; Arvinas, Inc) met its primary end point of progression-free survival (PFS) compared with fulvestrant (Faslodex; AstraZeneca) in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer (MBC) whose disease progressed following prior treatment with CDK 4/6 inhibitors and endocrine therapy. The clinically meaningful outcomes were observed in the phase …
Advancing Treatments for ET and CDK4/6 Resistance in HR+ Breast Cancer
By: Silas Inman From: targetedonc.com Multiple novel agents with diverse mechanisms of action are currently in development to overcome resistance to endocrine therapy (ET) and CDK4/6 inhibitors in hormone receptor–positive breast cancer. This ongoing research, highlighted in a session by Hope S. Rugo, MD, at the 42nd Annual Miami Breast Cancer Conference, aims to address the significant unmet clinical need …
Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer
By: Sheikh Zakaria, PharmD,Michele Riccardi, PharmD, BCPS From: pharmacytimes.com AT is a 38-year-old female who has stage 4 metastatic breast cancer that is positive for estrogen and progesterone receptor (ER+, PR+) and breast cancer gene (BRCA) 1/2 negative. She expressed concern to her pharmacist about using iron and multivitamin supplements for her breast cancer. She read an article about an …
Immunotherapies Spark Excitement in Triple-Negative Breast Cancer Treatment
By: Tony Berberabe, MPH From: targetedonc.com THE USE OF IMMUNOTHERAPY approaches in triple-negative breast cancer (TNBC) has resulted in diverse breakthroughs that leverage immune checkpoint inhibitors (ICIs). Expanded use of ICIs has led to the identification of different molecular subtypes that can help develop individualized treatment plans. Investigators in numerous trials are exploring immunotherapy in combination with existing treatment modalities …